SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Heart (CAMH)-What is this???
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Zwiener who wrote (8)2/18/1997 6:21:00 AM
From: Asymmetric   of 33
 
Quarter Reflects Product Evaluation

Cautionary statement by Arnold regarding stuffing the distribution
channel, meager such as it was, reflects buyers/distributors in
evaluation phase. Real sales will have to wait until completion
of research studies and FDA approval...and then of course purhasing
approval by hospitals/HMOs etc. My hope is that whole process
will be expedited, especially since the alternative is so much
more traumatic.(..and the other alternative is basically death!).

I'll post more excerpts in future posts regarding interview.

I don't know much about Igen, but ran across mention/discussion
of it at:

tradesmart.com

Go into the archives and you'll find a some posts.


Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News